|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Medivation, Inc. (NASDAQ:MDVN) today reiterated its rejection of Sanofi's substantially inadequate proposal to acquire the Company for $52.
France's Sanofi said it would move to oust the current board of Medivation if the latter does not engage in discussions about a transaction.
Shareholders have written consent to hold the target's board to task.
Checking the gauges for underperformance, none of them look good.
Pfizer reportedly made a bid for the cancer drug maker, rivaling Sanofi's $9.3 billion offer, but analysts say another company might be the best fit.
TheStreet highlights 3 stocks pushing the health care sector higher today.
Medivation (MDVN) stock is higher in early-afternoon trading on Wednesday, as Pfizer (PFE) reportedly considers a takeover bid.
Trade-Ideas LLC identified Medivation (MDVN) as a momo momentum candidate
Pfizer (PFE) has reportedly approached San Francisco based cancer drug maker Medivation (MDVN) about a buyout.
U.S. stock futures point lower on Wednesday, European shares trade mixed and Asian stocks finish with losses on global growth concerns.
The markets closed out the month of April with weekly losses and Apple was to blame.
The San Francisco target rejects the $9.3 billion offer, but biotech growth and a healthy pipeline mean Sanofi isn't desperate for Medivation's cancer treatments.
Benchmark indices slip after better-than-forecast data on first-quarter GDP but disappointing news on Eurozone consumer prices.
Apple might be down but other tech stocks, including Amazon and Facebook, are doing terrific, Cramer says.
Stocks remain lower by mid-afternoon Thursday as worries over the U.S. economy overshadow better-than-expected earnings from industry giants.
Thursday's parade of deals seem to answer a question that's been bugging health care investors for most of 2016: why haven't retreating biotech valuations sparked an uptick in M&A activity?
The tech-heavy Nasdaq drags broader markets into the green on Thursday morning after a strong earnings win from social network Facebook.
Medivation (MDVN) stock is rising in mid-morning trading on Thursday after receiving a takeover offer from Sanofi.
Stock futures set up for losses on Thursday after U.S. growth slows to its worst level in two years.
Trade-Ideas LLC identified Medivation (MDVN) as a pre-market leader candidate
The French pharmaceuticals company takes its campaign to snare the oncology specialist public.
U.S. stock futures are tumbling Thursday and European shares fall sharply after Japan's central bank disappoints investors by standing firm on rates.
Deutsche Bank jumps on brighter-than-expected first-quarter numbers but the prospect of order delays grounds shares in Airbus.
Biotech stocks are dominating the strong stock charts on our radar.
Here are Wednesday's top research calls, including downgrades for Boeing, Hershey, Spirit Airlines and Regeneron.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARE, ARII, CE, COWN, CPAC, CRCM, ESCA, FORR, HASI, HWKN, MDVN, PAAS, PMBC, PNNT, SPAR Downgrades: LSXMA, LSXMB, LSXMK, MY Initiations: ICBK, LENS Read on to get TheStreet Quant Ratings' detailed report:
Here are Tuesday's top research calls, including a pair of downgrades for Illumina, and upgrades for CarMax, PulteGroup and Panera Bread.
Medivation (MDVN) stock is soaring this morning as AstraZeneca (AZN) reportedly considers making a takeover offer.
A 5%-plus fall in oil prices drags down global stock benchmarks as well as BP, Shell, Total and other producers.
Three biotechs are among our four stocks showing strong technical momentum today.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.